Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002346651 | SCV002618953 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003102417 | SCV002992584 | likely benign | Neuroblastoma, susceptibility to, 3 | 2022-08-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003418455 | SCV004144013 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | ALK: PM2:Supporting, BP4, BP7 |